Immunocore appoints Brian Di Donato as Chief Financial Officer and Head of Strategy

NEXT STORY
Allogene Therapeutics Reports First Quarter 2020 Financial Results
PREV STORY
ProMIS Neurosciences develops novel antagonists for RACK1, a protein involved in numerous neurodegenerative diseases, including ALS
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Selecta Biosciences Announces Third Quarter 2018 Financial Results and Provides Corporate Update

 Prioritized head-to-head superiority clinical trial of SEL-212 compared to Krystexxa, expected to begin in ...

author_avatar
NASDAQ Market News

ClubCorp Charity Classic generates more than $1.4 million for charity through challenging 2020

author_avatar
NASDAQ Market News

Global In Vitro Diagnostics Quality Control Market (2021 to 2026) – Rising Demand for Multi-analyte Controls Presents Opportunities

author_avatar
NASDAQ Market News